Literature DB >> 10929056

Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators.

A Ariel1, O Lider, A Brill, L Cahalon, N Savion, D Varon, R Hershkoviz.   

Abstract

Migration of T cells into extravascular sites of inflammation is mediated by cell-cell and cell-matrix adhesion receptors, including the hyaluronan-binding glycoprotein, CD44. The biochemical nature of CD44 variants and the ligand specificity, function and the regulation of activation of CD44 expressed on various cell types have been extensively studied. However, little is still known about the short-term influence of cytokines and chemokines on the activation of CD44 on human T cells. Therefore, we studied the role of inflammatory mediators in regulating the adhesion of T cells from human peripheral blood to immobilized hyaluronan under static or shear stress conditions. We found that the CD44-dependent adhesion, under static and shear stress (i.e. relative gradual resistance to flow of 150 and 1500 s-1) conditions, of T cells to hyaluronan requires a T-cell activation of 2-3 hr and is regulated by the cross-linking of CD3, cytokines (e.g. interleukin-2 and tumour necrosis factor-alpha), and chemokines (e.g. MIP-1beta, interleukin-8, and RANTES). This T-cell adhesion was manifested by polarization, spreading and co-localization of cell surface CD44 with a rearranged actin cytoskeleton in hyaluronan-bound T cells. Thus, cytokines and chemokines present in the vicinities of blood vessel walls or present intravascularly in tissues where immune reactions take place, can rapidly activate the CD44 molecules expressed on T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929056      PMCID: PMC2327018          DOI: 10.1046/j.1365-2567.2000.00059.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.

Authors:  M C Levesque; B F Haynes
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 2.  Lymphocyte responses to chemokines.

Authors:  B Moser; M Loetscher; L Piali; P Loetscher
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

3.  Requirement for CD44 in activated T cell extravasation into an inflammatory site.

Authors:  H C DeGrendele; P Estess; M H Siegelman
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

4.  Dual role of the CD44 molecule in T cell adhesion and activation.

Authors:  Y Shimizu; G A Van Seventer; R Siraganian; L Wahl; S Shaw
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

5.  Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta.

Authors:  D D Taub; K Conlon; A R Lloyd; J J Oppenheim; D J Kelvin
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

6.  Post-receptor occupancy events in leukocytes during beta 1 integrin-ligand interactions.

Authors:  P Sánchez-Mateos; A G Arroyo; M A Balboa; F Sánchez-Madrid
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

Review 7.  Mechanisms regulating the binding activity of CD44 to hyaluronic acid.

Authors:  D Liu; T Liu; R Li; M S Sy
Journal:  Front Biosci       Date:  1998-07-01

8.  Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate.

Authors:  L E Esford; A Maiti; S A Bader; F Tufaro; P Johnson
Journal:  J Cell Sci       Date:  1998-04       Impact factor: 5.285

9.  Effects of phorbol esters on shape and locomotion of human blood lymphocytes.

Authors:  P C Wilkinson; J M Lackie; W S Haston; L N Islam
Journal:  J Cell Sci       Date:  1988-08       Impact factor: 5.285

10.  Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.

Authors:  T J Schall; K Bacon; R D Camp; J W Kaspari; D V Goeddel
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  14 in total

1.  Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage.

Authors:  Tomomi Metoki; Hiroshi Ohguro; Ikuyo Ohguro; Kazuhisa Mamiya; Tadashi Ito; Mitsuru Nakazawa
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

2.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 3.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

Review 4.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

Review 5.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

6.  Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4+ T Cells That Correlated with Reduced Risk of Infection in RV144 Trial.

Authors:  Kristen W Cohen; Yuan Tian; Casey Thayer; Aaron Seese; Robert Amezquita; M Juliana McElrath; Stephen C De Rosa; Raphael Gottardo
Journal:  J Immunol       Date:  2022-07-08       Impact factor: 5.426

7.  Flotillins are involved in the polarization of primitive and mature hematopoietic cells.

Authors:  Lawrence Rajendran; Julia Beckmann; Astrid Magenau; Eva-Maria Boneberg; Katharina Gaus; Antonella Viola; Bernd Giebel; Harald Illges
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

8.  TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells.

Authors:  Michal Barshishat; Amiram Ariel; Liora Cahalon; Yehuda Chowers; Ofer Lider; Betty Schwartz
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 9.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

Review 10.  Lipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and Cancer.

Authors:  Toshiyuki Murai
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.